ACBM ファイナンス： ACRO Biomedical Co Ltd AI分析

ホーム

株式

ACBM

財務状況

ACBM 財務

ACRO Biomedical Co Ltd

$0.02

終値： Mar 24, 16:00:00 GMT-4

$0.02

アフターマーケット：Mar 24, 20:00:00 GMT-4

概要予測収入配当財務状況

主要データ

前終値

$0.026

始値

$0.026

当日レンジ

$0.026 - $0.026

52週レンジ

$0.0007 - $0.036

取引高

平均取引高

配当利回り

1株当たり利益(TTM)

-0.00

時価総額

$1.5M

ACBMとは何ですか？

Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. The company is headquartered in Fishers, Indiana. The company went IPO on 2016-06-23. The firm is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle. The firm's business consists of selling cordyceps related products that is used in traditional Chinese medicine. Cordyceps is a fungus which is a combination of a caterpillar and a fungus, which is found at altitudes above 4500 meters (m) in Sikkim. The firm is engaged in the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers. The company sells products in bulk to companies who may use the Company's products as ingredients in their products or sell the products they purchase from the Company to their own customers.

特徴

リソース

市場

収入

貸借対照表

現金の流れ

年次

四半期

ACBM 収入

金額は百万米ドル単位。会計年度は2月から1月まで。

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
収入	0	0	0	0	0	1
収益成長率（YoY）	--	--	--	--	-100%	--
収益のコスト	--	--	--	0	0	0
売上総利益	--	--	--	0	0	0
販売、一般および管理	0	0	0	4	5	2
研究開発	--	--	0	4	10	5
運営費用	0	0	0	8	16	7
その他の非営業収入（費用）	--	--	--	--	--	--
税引前利益	0	0	0	-8	-15	-7
所得税費	0	0	0	0	0	0
純利益	0	0	0	-8	-15	-7
純利益成長率	--	--	-100%	-47%	113.99%	--
流通済み株式数（希薄化後）	60.04	60.04	60.04	60.04	60.04	53.84
株式変動（前年比）	0%	0%	0%	0%	12%	13%
EPS（希薄化）	0	0	0	-0.14	-0.26	-0.14
EPS成長率	750%	143%	-100%	-44%	86%	--
フリーキャッシュフロー	0	0	0	0	0	0
1株当たりフリーキャッシュフロー	--	--	--	--	--	--
粗利益	--	--	--	0%	0%	0%
営業利益率	0%	0%	0%	0%	0%	-700%
利益率	0%	0%	0%	0%	0%	-700%
フリーキャッシュフロー利益率	0%	0%	0%	0%	0%	0%
EBITDA	--	--	--	--	--	--
EBITDAマージン	--	--	--	--	--	--
D&A による EBITDA	--	--	--	--	--	--
営業利益	0	0	0	-8	-15	-7
営業利益率	0%	0%	0%	0%	0%	-700%
実効税率	0%	0%	0%	0%	0%	0%

Follow-Up Questions

ACRO Biomedical Co Ltd의 주요 재무제표는 무엇인가요?



최신 재무제표(Form-10K)에 따르면, ACRO Biomedical Co Ltd의 총 자산은 $0이며, 순損失입니다.

ACBM의 주요 재무 비율은 무엇인가요?



ACRO Biomedical Co Ltd의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.

ACRO Biomedical Co Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?



ACRO Biomedical Co Ltd の最大収益セグメントは Genie Retail Energy で、最新の利益発表における収益は 403,340,000 です。地域別に見ると、United States が ACRO Biomedical Co Ltd の主要市場であり、収益は 424,481,000 です。

ACRO Biomedical Co Ltd은 수익성이 있나요?



いいえ, 최신 재무제표에 따르면 ACRO Biomedical Co Ltd의 순損失은 $0입니다.

ACRO Biomedical Co Ltd에 부채가 있나요?



いいえ, ACRO Biomedical Co Ltd의 부채는 0입니다.

ACRO Biomedical Co Ltd의 발행 주식은 몇 주인가요?



ACRO Biomedical Co Ltd의 총 발행 주식은 60.04주입니다.

ACRO Biomedical Co Ltd (ACBM) 財務

ACBM 株価推移チャート